Corporate News

Inovio (INO) experienced a modest rise of 1.01 % during the 24‑hour period concluding at 07:49 AM Central Europe on Wednesday, 21 October 2026. At the time of reporting, a single Inovio share could be purchased for approximately USD 1.01 on major exchanges. The company’s outstanding share base stands at 103.4 million, which translates to a market capitalization of USD 104.4 million. In the last 24 hours, the trading volume for Inovio shares totaled roughly USD 2.1 million.

Over the month ending on 30 September, Inovio’s share price declined 19.35 %, a downturn that has tempered investor enthusiasm. The 200‑day simple moving average (SMA) sits at USD 1.30, providing a benchmark for short‑term trend analysis. Historically, Inovio’s price has demonstrated significant volatility: the 52‑week high reached USD 2.72 on 17 December 2025, while the 52‑week low fell to USD 0.56 on 30 July 2026.

Peer Performance

Within the same 24‑hour window, the following peer stocks displayed varied movements:

  • Armata (ARMP): down 8.9 %, now at USD 3.20. Market cap: USD 125.3 million.
  • Amaero (AMRO): up 24.67 %, now at USD 5.21. Market cap: USD 124.7 million.
  • Acumen (ABOS): up 4.73 %, now at USD 2.02. Market cap: USD 122.2 million.
  • Korro Bio (KRRO): up 4.95 %, now at USD 9.44. Market cap: USD 124.4 million.
  • Defi Development (DFDV): down 3.18 %, now at USD 3.87. Market cap: USD 123.0 million.

Company Profile

Inovio Pharmaceuticals, Inc., headquartered in Plymouth Meeting, United States, is a biotechnology firm focused on the research and development of innovative therapeutics. The company’s portfolio includes cancer DNA vaccines, infectious DNA vaccines, anti‑inflammatory agents, and animal health products. Inovio’s products aim to address unmet needs within the U.S. healthcare sector, offering new avenues for disease prevention and treatment.

Founded with an Initial Public Offering on 12 February 1998, Inovio has maintained a presence on the Nasdaq stock exchange, providing investors with a platform to participate in the company’s growth trajectory. Further details regarding Inovio’s research initiatives, product pipeline, and corporate governance can be found on the company’s official website at www.inovio.com .